Part 2: Keeping up with the Chemos Series: Administration of Lenvatinib/pembrolizumab
SGO On the Go
by The Society of Gynecologic Oncology
1w ago
This is the second of the three-part podcast series, Keeping up with the Chemos on Lenvatinib/pembrolizumab. Our multidisciplinary panel will discuss the important information about creating chemotherapy orders, the drug preparation and administration of Lenvatinib/pembrolizumab. Focusing on specialty pharmacy and patient education when taking Lenvatinib at home. The session ends with general take home points on administration and toxicity prevention interventions.  2022-2023 SGO Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MD Judith A. Smith, B.S., P ..read more
Visit website
Part 1: Keeping up with the Chemos Series: Preparing to Give Lenvatinib/pembrolizumab
SGO On the Go
by The Society of Gynecologic Oncology
1w ago
This is the first of the three-part podcast series, Keeping up with the Chemos on Lenvatinib/pembrolizumab. After going over some general information on Lenvatinib/pembrolizumab including mechanism of action and indication. The multidisciplinary panel will discuss the aspects of getting a team of nursing, pharmacy, Gynecologic Oncologist educated and prepared for giving Lenvatinib/pembrolizumab. The session wraps up with some key take home points on Lenvatinib/pembrolizumab.   2022-2023 SGO Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MD Judith A. Smi ..read more
Visit website
ERAS Guidelines: Same Day Discharge (SDD)
SGO On the Go
by The Society of Gynecologic Oncology
1M ago
In this podcast, we will focus on same day discharge as part of Enhanced Recovery after Surgery (ERAS). Over the past two decades, and especially after the publication of the GOG LAP2 trial, minimally invasive surgery has been widely adopted in gynecologic oncology, as it is associated with lower rates of complications, and improved postoperative recovery and return to normal activity.  Postoperative hospitalization is typically shorter after minimally invasive (MIS) hysterectomy, and many patients may even be candidates for discharge on the day of surgery, so-called same-day discharge (S ..read more
Visit website
Immunotherapy Part 3: Common Controversies and Remaining Questions
SGO On the Go
by The Society of Gynecologic Oncology
3M ago
This episode is part 3 of the Immunotherapy podcast series, which continues discussion of common controversies affecting the use of immune checkpoint inhibitors (ICIs) in the clinic, such as optimal dosing strategies, influence of toxicity on response and survival, and sequencing. Moderator: Karin K. Shih, MD Gynecologic Oncologist & Assistant Professor - Zucker School of Medicine at Hofstra/Northwell Speakers: Erin Zacholski, PharmD, BCOP Assistant Professor - VCU School of Pharmacy Clinical Pharmacy Specialist, Gynecologic Oncology -  VCU Health Massey Cancer Center Sarah Hayward ..read more
Visit website
Part 3: Updates and Highlights from Summer NRG Oncology 2023
SGO On the Go
by The Society of Gynecologic Oncology
4M ago
Join Dr. Robert Neff as he interviews Drs. Kathleen Moore and Charles Leath, III to discuss the latest NRG Oncology updates on upcoming studies, research, and trials. The focus for the podcast is to bridge the gaps between SGO members and NRG Oncology.    Some questions covered during the interview:  Since NRG just celebrated its 10-year anniversary during the Summer Meeting, what is the vision for NRG in the next 10 years? What are some of the successes within the past year for the Ovary Subcommittee? What were the most important highlights from the Cervix and Vulvar Subcommit ..read more
Visit website
Locally Advanced Cervical Cancer: Discussion of Radiation Techniques & Management
SGO On the Go
by The Society of Gynecologic Oncology
5M ago
Episode three of the Radiation Therapy podcast series discusses radiation techniques and management with regard to locally advanced cervical cancer.  Host/Moderator: Leigh A. Cantrell, MD, MSPH Professor, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology - University of Virginia Guest Speaker: Kara Romano, M.D. Assistant Professor, Department of Radiation Oncology - University of Virginia Sound engineered and produced by Tanya Colomb on behalf of the Society of Gynecologic Oncology ..read more
Visit website
Diversity and Inclusion in Clinical Trials
SGO On the Go
by The Society of Gynecologic Oncology
5M ago
Join Dr. Janelle Darby, member of the SGO Clinical Trials Management/Concepts Subcommittee, as she interviews Drs. Evan Graboyes, Jeffrey Hines, and Bhavana Pothuri, addressing continued efforts to improve inclusion of racially and ethnically diverse patients in clinical trials.    Some topics covered during the interview: Barriers to clinical trial enrollment and retention among racially and ethnically diverse patient populations. Role of cooperative research groups in improving access to clinical trials for racially and ethnically diverse patient populations.  Discussion of r ..read more
Visit website
ERAS Guidelines: Surgical Site Infection Reduction Bundle (SSI Bundle)
SGO On the Go
by The Society of Gynecologic Oncology
8M ago
This podcast focuses on the surgical site infection reduction bundle as part of the ERAS guidelines that was first published in 2016 and updated in 2019, and the 2020 vulvar and vaginal surgeries ERAS guidelines. Before we dive into the SSI reduction bundle, we want to highlight the importance of patient education and participation in any ERAS protocol. Pre-operative education and psychological preparation is critical. Written information was determined to be superior to verbal in a randomized clinical trial in gynecologic oncology surgery. 2023-2024 SGO ERAS Subcommittee Members and Speaker ..read more
Visit website
Part 3: Keeping up with the Chemos Series: Follow up Monitoring Between Cycles (Trabectedin and Doxorubicin)
SGO On the Go
by The Society of Gynecologic Oncology
8M ago
This is the last of the three-part podcast series, Keeping up with the Chemos on Trabectedin and Doxorubicin. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trabectedin and Doxorubicin. When to dose adjust and hold or even discontinue Trabectedin and Doxorubicin. Once again, the podcast ends with take home points for patient monitoring and side effects while on Trabectedin and Doxorubicin.   2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MD Jennifer MacDonald, PharmD, BCOP Speakers:Sminu Bose ..read more
Visit website
Part 2: Keeping up with the Chemos Series: Administration of Trabectedin and Doxorubicin
SGO On the Go
by The Society of Gynecologic Oncology
8M ago
This is the second of the three-part podcast series, Keeping up with the Chemos on Trabectedin and Doxorubicin. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trabectedin and Doxorubicin. Focusing on oral dosing, infusion pump setup, lab examinations, and patient education. The session ends with general take home points on administration and toxicity prevention interventions. 2023-2024 SGO Chemotherapy and Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MD  Jennifer MacDonald, PharmD, BCOP Speakers ..read more
Visit website

Follow SGO On the Go on FeedSpot

Continue with Google
Continue with Apple
OR